Simulations Plus (NASDAQ:SLP) Share Price Passes Above 200 Day Moving Average – Here’s What Happened

Simulations Plus, Inc. (NASDAQ:SLP)’s share price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $15.59 and traded as high as $16.74. Simulations Plus shares last traded at $15.88, with a volume of 172,685 shares.

Wall Street Analysts Forecast Growth

SLP has been the topic of a number of recent research reports. Wall Street Zen raised Simulations Plus from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. TD Cowen dropped their price objective on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 10th. Finally, Weiss Ratings cut shares of Simulations Plus from a “sell (d)” rating to a “sell (d-)” rating in a research report on Thursday, May 21st. Three research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $24.40.

Simulations Plus Stock Performance

The stock’s fifty day moving average price is $14.34 and its 200-day moving average price is $15.59. The company has a market capitalization of $320.78 million, a P/E ratio of -5.07 and a beta of 1.33.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings data on Thursday, April 9th. The technology company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.08. The firm had revenue of $24.29 million during the quarter, compared to the consensus estimate of $21.66 million. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. On average, research analysts predict that Simulations Plus, Inc. will post 0.85 EPS for the current fiscal year.

Institutional Investors Weigh In On Simulations Plus

Several hedge funds and other institutional investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Simulations Plus by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock worth $233,000 after buying an additional 390 shares during the period. Bank of New York Mellon Corp grew its holdings in Simulations Plus by 1.3% in the 1st quarter. Bank of New York Mellon Corp now owns 63,592 shares of the technology company’s stock worth $752,000 after acquiring an additional 844 shares during the last quarter. Deutsche Bank AG boosted its stake in shares of Simulations Plus by 5.9% during the 4th quarter. Deutsche Bank AG now owns 15,825 shares of the technology company’s stock valued at $288,000 after purchasing an additional 875 shares in the last quarter. Prudential Financial Inc. boosted its stake in shares of Simulations Plus by 5.7% during the 2nd quarter. Prudential Financial Inc. now owns 17,213 shares of the technology company’s stock valued at $300,000 after purchasing an additional 930 shares in the last quarter. Finally, Invesco Ltd. lifted its position in Simulations Plus by 3.8% during the 2nd quarter. Invesco Ltd. now owns 36,452 shares of the technology company’s stock valued at $636,000 after acquiring an additional 1,323 shares during the period. 78.08% of the stock is owned by institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.